CANY
HLF icon

Caxton Associates (New York)’s Herbalife HLF Stock Holding History

Caxton Associates (New York)’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,000,000
Closed -$22.6M – 196
2013
Q2 		$22.6M Buy
+1,000,000
New +$21.3M 1.14% 17

Other funds holding HLF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caxton Associates (New York)'s HLF Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Herbalife (HLF) in Q3 2022, closing a stake of 60,823 shares — an estimated $1.24M sold.

Caxton Associates (New York) first reported a position in HLF in Q4 2017 and held it in 6 quarters. The position peaked at $1.24M in Q2 2022. 201 funds tracked by Wall St. Rank hold HLF as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Herbalife position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 60,823 Herbalife shares in Q3 2022, an estimated $1.24M.
  • Caxton Associates (New York) first reported a position in Herbalife in Q4 2017 and held it in 6 quarters.
  • Caxton Associates (New York)'s Herbalife position peaked at $1.24M in Q2 2022.
  • 201 funds tracked by Wall St. Rank held Herbalife as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.